Recalls / Active ingredient / Doxazosin Mesylate

Doxazosin Mesylate

8 FDA drug recalls involving the active ingredient “Doxazosin Mesylate”.

Date	Class	Product	Firm
2026-01-21	Class III	Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA),	Unichem Pharmaceuticals USA Inc.
2024-12-23	Class II	Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specia	Viatris Inc
2024-12-23	Class II	Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Special	Viatris Inc
2023-03-16	Class II	Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis	Northwind Pharmaceuticals LLC
2023-02-07	Class II	Doxazosin Tablets USP, 8 mg, Rx Only, Packaged in: a) 100 Tablets NDC 16729-415-01 UPC 3 16729 41501 9; b) 1,0	Accord Healthcare, Inc.
2023-02-07	Class II	Doxazosin Tablets USP, 2 mg, Rx Only, Packaged as: a) 100-count bottle NDC 16729-414-01 UPC 3 16729 41401 2; b	Accord Healthcare, Inc.
2023-02-07	Class II	Doxazosin Tablets USP, 4 mg, Rx Only, Packaged as: a) 100-count bottle NDC 16729-213-01 UPC 3 16729 21301 1; b	Accord Healthcare, Inc.
2023-02-07	Class II	Doxazosin Tablets USP 1 mg, Rx Only, Packaged as: a) 100-count bottle NDC 16729-211-01 UPC 3 16729 21101 7; b)	Accord Healthcare, Inc.